Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 40 of about 72 companies and 92 funds for replaced
Company Exchange Symbol Last price Quote change Market cap
Aspen Insurance Holdings Limited Perp. Preferred Income Equity Replacement Secs (PIERS) (Bermuda) NYSE AHL-CL 65.30 298.82M
REPLACEMENT PARTS, INC. Private
Replacement Parts works Bumper to Bumper. The company's subsidiary Crow- Burlingame operates about 160 stores under the Bumper To Bumper banner in ...
Ultragenyx Pharmaceutical Inc NASDAQ RARE 66.72 -0.94 (-1.39%) 2.69B
Ultragenyx Pharmaceutical Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the identification, acquisition, development, and ...
ProMetic Life Sciences Inc. TSE PLI 2.24 +0.04 (1.82%) 1.50B
Prometic Life Sciences Inc (ProMetic) is a Canada-based biopharmaceutical company. The Company has two segments: Small Molecule Therapeutics and ...
Home Meal Replacement SA BME HMR 2.07 0.00 (0.00%) 34.12M
Home Meal Replacement SA is a Spain-based company engaged in the management of restaurants. The Company focuses on the processing, packaging and ...
Sangamo Therapeutics Inc NASDAQ SGMO 4.65 +0.60 (14.81%) 317.80M
Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., is focused on translating science into genomic therapies that transform patients' lives using ...
PROMETIC LIFE SCIE COM NPV OTCMKTS PFSCF 1.68 +0.06 (3.90%) 1.08B
Stryker Corporation NYSE SYK 131.90 -0.38 (-0.28%) 49.29B
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and ...
PROMETIC LIFE SCIENCES FRA PJ2 1.48 0.00 (0.00%)
Novelion Therapeutics Inc (USA) NASDAQ NVLN 10.90 +0.16 (1.49%) 201.99M
Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of ...
ConforMIS Inc NASDAQ CFMS 5.14 +0.11 (2.19%) 217.04M
ConforMIS, Inc. is a medical technology company that uses its iFit Image-to- Implant technology platform to develop, manufacture and sell joint replacement ...
ULTRAGENYX PHARM. DL-,001 FRA UP0 61.59 -0.61 (-0.99%)
Novelion Therapeutics Inc TSE NVLN 14.52 +0.12 (0.83%) 270.62M
Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of ...
STRYKER CORP. DL-,10 FRA SYK 122.44 -0.56 (-0.45%)
Stryker SWX SYK 130.90 0.00 (0.00%)
NOVELION THERAPEUTICS FRA QLTA 9.84 +0.15 (1.58%)
SANGAMO BIOSCIENES DL-,01 ETR GBY 0.0000
SANGAMO THERAP.INC.DL-,01 FRA GBY 4.06 0.00 (0.00%)
Sangamo Therapeutics SWX SGMO 4.20 0.00 (0.00%)
PhaseRx Inc NASDAQ PZRX 1.50 0.00 (0.00%) 17.70M
PhaseRx, Inc is a biopharmaceutical company developing a portfolio of mRNA products to correct life-threatening inherited liver diseases in children.
Show all 72 companies »
Mutual Fund Symbol Nav Nav change
Fidelity Income Replacement 2038 Fund FIRVX 60.29 +0.13 (0.22%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Income Replacement 2042 Fund FIXRX 61.72 +0.15 (0.24%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Income Replacement 2030 Fund FIRQX 61.97 +0.13 (0.21%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Income Replacement 2028 Fund FIRPX 62.79 +0.13 (0.21%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Income Replacement 2040 Fund FIRWX 61.51 +0.14 (0.23%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2032 Fund Class A FIARX 58.88 +0.12 (0.20%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2028 Fund Class M FTRPX 62.77 +0.13 (0.21%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2024 Fund Class M FRNTX 59.85 +0.11 (0.18%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2038 Fund Class A FARVX 60.32 +0.14 (0.23%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2022 Fund Class M FRTMX 59.87 +0.09 (0.15%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2038 Fund I Class FIIVX 60.29 +0.14 (0.23%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2038 Fund Class C FCRVX 59.84 +0.13 (0.22%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2018 Fund Class A FRKAX 53.93 0.00 (0.00%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2024 Fund Class A FRNAX 59.88 +0.11 (0.18%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2028 Fund Class A FARPX 62.79 +0.13 (0.21%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2038 Fund Class M FTRVX 60.24 +0.13 (0.22%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2018 Fund I Class FRKIX 53.94 0.00 (0.00%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2042 Fund Class A FARFX 61.68 +0.14 (0.23%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Advisor Income Replacement 2026 Fund Class M FIOTX 61.84 +0.12 (0.19%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Fidelity Income Replacement 2018 Fund FIRKX 53.94 0.00 (0.00%)
The investment seeks total return through a combination of current income and capital growth. The fund invests in a combination of Fidelity� equity funds, bond ...
Show all 92 funds »